At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 90 enrolled
Drug / intervention
Bupivacaine 0.25% with epinephrine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparative Study for Evaluation of the Analgesic Profile of Ultrasound-Guided Modified Pectoral Nerves Block Versus Serratus Plane Block in Major Breast Cancer Surgery
In Brief
A Phase 2 clinical trial evaluating Bupivacaine 0.25% with epinephrine for Postoperative Pain. Completed, enrolled 90 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the analgesic profile of modified pectoral nerves block and serratus plane block in patients undergoing mastectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesEgypt
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
First PostedOct 2016
Primary CompletionDec 2017
Study CompletionDec 2017
TodayJul 2026
First PostedOct 27, 2016
Enrollment StartOct 1, 2016
Primary CompletionDec 4, 2017
Study CompletionDec 11, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.7 years ago
Interventions
Bupivacaine 0.25% with epinephrinedrug
Bupivacaine 0.25% with epinephrinedrug